(Q35563879)

English

Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation

scientific article published on November 1, 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

Europe PubMed Central

Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

transition metal

1 reference

based on heuristic

inferred from title

free radical scavengers

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568008

23 March 2024

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Charles van Ypersele de Strihou

2

object named as

Charles van Ypersele de Strihou

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

author name string

Toshio Miyata

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0003986103004284?httpAccept=text/xml

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

https://api.elsevier.com/content/article/PII:S0003986103004284?httpAccept=text/plain

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Archives of Biochemistry and Biophysics

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

419

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

50-54

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits

2

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM

3

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

4

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications

5

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

6

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation

7

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids

12

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Carbonyl compounds cross-link cellular proteins and activate protein-tyrosine kinase p60c-Src

13

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage

14

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms

15

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis

16

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen

17

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction

18

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose

20

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Role of oxidative stress in development of complications in diabetes

22

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Chelating activity of advanced glycation end-product inhibitors

23

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Transition metals redox: reviving an old plot for diabetic vascular disease

24

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

25

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Anti-Hypertensive Agents Inhibit In Vivo the Formation of Advanced Glycation End Products and Improve Renal Damage in a Type 2 Diabetic Nephropathy Rat Model

27

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine

29

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

30

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.

31

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

32

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

33

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

34

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

35

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect

36

1 reference

10.1016/J.ABB.2003.08.010

https://api.crossref.org/works/10.1016/J.ABB.2003.08.010

23 March 2024

Identifiers

10.1016/J.ABB.2003.08.010

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35563879&oldid=2255069213"